-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $23

Benzinga·02/24/2025 15:59:42
Listen to the news
RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and lowers the price target from $47 to $23.